Definition And Core Principles
- Nucleic Acid Amplification Test (NAAT) is a molecular diagnostic method that detects and amplifies specific nucleic acid sequences of the Mycobacterium tuberculosis complex (MTBC) directly from clinical specimens.
- It is the preferred initial diagnostic tool in pediatric tuberculosis due to the paucibacillary nature of the disease in children.
- The mechanism involves DNA or RNA extraction from the sample, followed by target amplification utilizing specific primers and probes.
- Common gene targets include the rpoB gene (utilized for MTB detection and rifampicin resistance), IS6110, and 16S rRNA.
- Detection is achieved via fluorescence, hybridization, or colorimetric methods in automated or semi-automated platforms.
Types Of Platforms Used In Pediatrics
| Platform | Characteristics And Utility |
|---|---|
| Cartridge-Based NAAT (CBNAAT / GeneXpert MTB/RIF) | Utilizes semi-nested real-time PCR. Detects MTB and rifampicin resistance via five overlapping rpoB probes. World Health Organization recommended as an initial test. Provides results within 2 hours. |
| Truenat MTB/RIF | Portable, battery-operated, chip-based real-time PCR. Highly suitable for peripheral laboratories and point-of-care use in children. |
| Line Probe Assay (LPA) | Includes GenoType MTBDRplus and MTBDRsl for first- and second-line drug resistance detection. Can be performed from positive cultures or direct specimens. Generates results in 24 hours. |
| Loop-Mediated Isothermal Amplification (LAMP / TB-LAMP) | A simple, equipment-light method utilized primarily for resource-limited settings. |
Clinical Indications In Pediatric Practice
- All children presenting with presumptive pulmonary or extrapulmonary TB (e.g., fever, cough lasting greater than 2 weeks, weight loss, contact history).
- Smear-negative or smear-scanty cases, which represent the majority of pediatric presentations.
- High-risk groups including HIV co-infection, severe acute malnutrition, immunocompromised states, and suspected drug-resistant TB.
- Extrapulmonary TB evaluation utilizing specific samples like cervical lymphadenopathy (FNAC), tuberculous meningitis (CSF), pleural or pericardial effusion, abdominal TB, and osteoarticular TB.
- Critically ill children requiring rapid diagnosis prior to the availability of culture results, which typically take 6-8 weeks.
Sample Collection And Processing In Children
- Pulmonary TB: Two to three early-morning gastric aspirates (preferred in children less than 8 years old, requiring 5-10 ml volume), induced sputum using 3% hypertonic saline nebulization with chest physiotherapy, or bronchoalveolar lavage.
- Extrapulmonary TB: Fine-needle aspiration cytology (FNAC) for lymph nodes yields high cellularity. Cerebrospinal fluid (minimum 2-3 ml for tuberculous meningitis), sterile body fluids, and tissue biopsies are also utilized.
- Direct testing is possible without prior decontamination in most automated platforms.
- Multiple samples increase diagnostic yield; gastric aspirates must be collected after overnight fasting with proper nasogastric tube placement.
Interpretation Of Results And Management
| NAAT Result | Clinical Interpretation And Action |
|---|---|
| MTB Detected | Initiate daily Anti-Tubercular Therapy (ATT). If rifampicin resistance is identified, initiate shorter or longer MDR-TB regimen per current protocols. |
| MTB Not Detected | Does not definitively exclude TB. Integrate with clinical features, chest radiograph, Mantoux/IGRA, histopathology, and overall treatment response. |
| Rifampicin Resistant | Avoid rifampicin in the treatment regimen. Confirm resistance with phenotypic Drug Susceptibility Testing (DST) on culture. |
| Invalid Or Error | Repeat the test using a fresh sample. Check for technical issues or presence of inhibitors in the sample. |
Advantages And Limitations
| Feature | Advantages | Limitations |
|---|---|---|
| Diagnostic Yield | High sensitivity of 60-90% in pulmonary TB (surpassing smear microscopy at 30-50%) and 40-70% in extrapulmonary TB. High specificity greater than 95%. | Lower sensitivity in smear-negative extrapulmonary TB and culture-negative cases, presenting a false negative rate of 20-40%. |
| Drug Resistance | Enables simultaneous detection of rifampicin resistance, facilitating early initiation of MDR-TB regimens. | Does not provide full phenotypic DST; traditional culture remains the gold standard for second-line drugs. |
| Viability Assessment | Rapid turnaround time (hours versus weeks for culture). Works efficiently on small-volume, paucibacillary pediatric samples. | Cannot distinguish live from dead bacilli; a positive result may persist post-treatment. Not utilized for routine treatment monitoring. |
Special Considerations In Infants And Young Children
- Infants and young children have a higher proportion of extrapulmonary and disseminated TB; diagnostic yield improves significantly with multiple gastric aspirates and lymph node sampling.
- Gastric lavage technique is critical, requiring proper tube placement, early morning collection, and neutralization if processing is delayed.
- In neonates, use smallest volume platforms (like Truenat) combined with chest radiograph and CSF analysis.
- In HIV-exposed infants, NAAT is mandatory to differentiate TB from other opportunistic infections causing failure to thrive and pneumonia.